Zobrazeno 1 - 10
of 2 345
pro vyhledávání: '"Real-world study"'
Publikováno v:
Journal of Traditional Chinese Medical Sciences, Vol 11, Iss 4, Pp 423-427 (2024)
Objective: To determine the efficacy and safety of the Yinmei Kuijie decoction combined with 5-aminosalicylic acid (5-ASA) in treating mildly to moderately active ulcerative colitis (UC) under real-world conditions. Methods: This multicenter, prospec
Externí odkaz:
https://doaj.org/article/ebc6bbeed26f4eeca9a27ea6a6e4c90a
Publikováno v:
BMC Surgery, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Objective This study aims to evaluate the real-world effectiveness of applying different levels of Enhanced Recovery After Surgery (ERAS) guidelines to video-assisted thoracic day surgery (VATS). The goal is to determine the optimal degree o
Externí odkaz:
https://doaj.org/article/ebec8a8e68a34de39babf8f39178c4b8
Autor:
Yuyu Xu, Zhiduan Cai, Shuangxing Chen, Qingling Xie, Zewen Zhou, Haishan Zhuang, Ning Liang, Jiaywei Tsauo, Guibin Xu
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background The effectiveness of metallic stents in treating ureteral strictures following surgery and radiotherapy for gynecological tumors is currently uncertain. We aimed to investigate the efficacy and safety of thermo-expandable metallic
Externí odkaz:
https://doaj.org/article/fc3a4ed63db449cb933e8dbeb0a77520
Autor:
Yuxiao Liu, Xiaofan Guo, Peijun Xu, Yuning Song, Jing Huang, Xingyun Chen, Wenbo Zhu, Jihui Hao, Song Gao
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 9, Pp 799-812 (2024)
Objective: Little progress has been made in recent years using first-line chemotherapy, including gemcitabine combined with nab-paclitaxel, FOLFIRINOX, and NALIRIFOX, for advanced pancreatic adenocarcinoma (APC). In addition, the optimal second-line
Externí odkaz:
https://doaj.org/article/c785497a58fe4bb7b163d701bd59d598
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3901-3911 (2024)
Bolin Zhu, Pengfei Jin, Jianchun Li, Yuanchao Zhu Department of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Assessment of Clinical Drugs R
Externí odkaz:
https://doaj.org/article/f68aafe8fada4352be06fc7562b0b9d1
Autor:
Chen Y, He M, Zhao SJ, Chen YJ, Zhang YQ, Chen XL, Yang CJ, Luo YZ, Nandakumar KS, Xing ZX, Tian M
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 5509-5519 (2024)
Yong Chen,1 Mang He,1 Si-Jin Zhao,2 Yan-Juan Chen,1 Yong-Qiao Zhang,2 Xiao-Long Chen,2 Chuan-Jie Yang,2 Yu-Zhuo Luo,2 Kutty Selva Nandakumar,3 Zhou-Xiong Xing,4 Mei Tian1 1Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medica
Externí odkaz:
https://doaj.org/article/02327252800b404180176f3112af191a
Autor:
Peiretti E, Ascardi C, Bandello F, Boscia F, Varano M, Bartezaghi M, De Santi L, Staurenghi G
Publikováno v:
Clinical Ophthalmology, Vol Volume 18, Pp 2183-2191 (2024)
Enrico Peiretti,1 Chiara Ascardi,2 Francesco Bandello,3 Francesco Boscia,4 Monica Varano,5 Marta Bartezaghi,2 Lorenzo De Santi,2 Giovanni Staurenghi6 1Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera, Universitaria di Cagliari, C
Externí odkaz:
https://doaj.org/article/953177601a554309bf474a71f3ce0881
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 841-854 (2024)
Wenzhen Ge,1 Ning Wu,1 Chieh-I Chen,1 Timothy J Inocencio,1 Patrick R LaFontaine,2 Frank Seebach,3 Matthew Fury,4 James Harnett,1 Emily S Ruiz5 1Department of Health Economics and Outcomes Research, Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA;
Externí odkaz:
https://doaj.org/article/745e603586c047459b898121a804e0f5
Autor:
Martinez FJ, Papi A, Welte T, Singh D, Galkin DV, Guasconi A, Pirondi S, Georges G, Imperato J, Hermans R
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1433-1445 (2024)
Fernando J Martinez,1 Alberto Papi,2 Tobias Welte3,4 ,† Dave Singh,5 Dmitry V Galkin,6 Alessandro Guasconi,7 Stefania Pirondi,7 George Georges,7 Joseph Imperato,8 Ruben Hermans9 1Weill Cornell Medicine, New York–Presbyterian Hospital, New York, N
Externí odkaz:
https://doaj.org/article/e2ff96e0ea594d11848e624cb4d2bdb9
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background In the era of second-generation ALK tyrosine kinase inhibitors (ALK-TKIs), there was a paucity of data regarding the progression patterns, resistant mechanisms, and subsequent therapeutic approaches for ALK-positive (ALK+) non-sma
Externí odkaz:
https://doaj.org/article/455fd9db100f4edfb8ffd74a06e877a5